Sarepta Therapeutics Cash Flow Statement (2010-2026) | SRPT

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-81.41M-48.14M-74.35M-105.03M-231.48M-257.74M329.33M-516.75M-23.94M-40.94M296.05M36.15M6.48M33.61M66.69M-447.51M196.89M-179.95M-283.21M330.96M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
29.00M26.70M29.78M29.20M102.89M50.42M50.51M41.25M47.40M48.10M45.81M45.20M50.50M43.50M70.53M41.43M37.00M16.40M45.68M33.67M
Gains from Sales and Divestitures (Quarter)
0.28M0.39M0.39M0.64M0.04M0.04M0.04M0.04M0.04M0.23M
Gains from Investment Securities (Quarter)
18.004.50M-4.46M0.71M0.86M0.93M-13.13M1.08M1.11M1.14M80.20M0.28M-5.17M1.25M23.75M5.23M-4.59M5.19M20.01M1.29M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
248.48M557.93M5.95M6.27M5.78M
Cash from Operations (Quarter)
-109.15M-124.33M-29.33M-101.17M-66.81M-64.96M-92.39M-209.40M-122.23M-114.71M-54.66M-242.08M14.94M-70.70M92.05M-583.44M261.34M-14.59M131.21M-202.68M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.05M-1.41M-3.06M-6.13M-8.65M-11.59M-12.60M-13.33M-12.40M-10.46M-10.62M-6.80M-1.91M-1.87M-1.13M-0.38M-0.53M
Depreciation & Amortization (CF) (Quarter)
8.45M10.49M10.14M10.72M9.89M10.70M10.55M11.30M10.79M10.93M11.37M8.74M8.72M9.81M10.46M9.98M10.84M18.45M5.25M10.59M
Change in Working Capital
Change in Receivables (Quarter)
9.32M22.27M3.20M25.20M25.66M-2.35M13.12M9.21M12.97M82.05M81.47M-21.52M-18.81M74.53M167.46M57.38M-132.08M-131.56M2.49M-3.42M
Change in Inventory (Quarter)
28.42M19.71M27.26M4.69M10.68M26.54M8.88M0.31M26.69M26.61M94.10M60.51M102.46M70.54M161.66M177.36M59.19M83.02M-18.48M69.76M
Change in Account Payables (Quarter)
-58.34M-210.47M
Change in Accured Expenses (Quarter)
51.41M-52.96M69.81M-5.02M86.52M53.20M12.88M-67.54M-26.13M-17.55M61.09M-92.84M77.59M1.69M124.21M8.98M-51.15M-103.17M249.62M-3.44M
Other Working Capital Changes (Quarter)
-9.34M-22.50M-36.45M-22.00M-8.92M-35.83M-22.49M22.52M-32.15M12.52M-4.69M-50.42M10.04M4.96M45.09M-85.40M122.66M-7.07M49.59M-274.92M
Investing Activities
Capital Expenditures (Quarter)
5.89M9.24M2.21M5.55M9.08M8.23M7.96M9.48M17.91M29.67M19.04M32.44M29.17M37.26M38.08M43.65M31.80M22.93M3.59M2.08M
Change in Intangibles (Quarter)
-99.69M1.43M0.09M0.04M101.86M10.00M-10.00M2.24M0.19M5.31M-7.74M1.00M
Change in Acquisitions & Divestments (Quarter)
226.00M30.00M77.15M399.57M446.50M448.83M415.62M475.81M528.22M477.69M261.47M297.84M965.11M40.76M68.63M86.55M99.94M38.89M
Cash from Investing Activities (Quarter)
321.06M20.27M-2.58M-785.81M-289.99M19.12M9.80M12.49M96.63M-210.57M-64.36M218.80M-98.53M-128.82M764.12M-291.18M32.21M232.40M96.21M-134.39M
Financing Activities
Other financing activities (Quarter)
1.43M0.55M14.78M
Cash from Financing Activities (Quarter)
3.53M5.90M549.25M4.99M0.34M216.43M10.75M101.80M5.86M15.40M1.94M22.14M39.92M13.76M48.99M12.47M-23.82M-117.79M-39.21M0.24M
Additional items
Change in Cash (Quarter)
215.44M-98.16M517.35M-881.99M-356.47M170.58M-71.85M-95.11M-19.74M-309.87M-117.07M-1.14M-43.67M-185.77M905.15M-862.14M269.73M100.03M188.21M-336.83M
Free Cash Flow (Quarter)
-115.04M-133.57M-31.53M-106.73M-75.89M-73.19M-100.36M-218.88M-140.14M-144.38M-73.70M-274.52M-14.22M-107.96M53.96M-627.09M229.54M-37.52M127.61M-204.76M
Net Cash Flow (Quarter)
215.44M-98.16M517.35M-881.99M-356.47M170.58M-71.85M-95.11M-19.74M-309.87M-117.07M-1.14M-43.67M-185.77M905.15M-862.14M269.73M100.03M188.21M-336.83M